Skip to content

Occipital alpha lateralization during a visual directed attention task in adults with ADHD as compared with typically developed adults and adults with an autism spectrum disorder.

Occipital alpha lateralization during a visual directed attention task in adults with ADHD as compared with typically developed adults and adults with an autism spectrum disorder. - Alpha-lateralization in ADHD

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON32770
Enrollment
60
Registered
2009-11-25
Start date
2009-12-16
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

attentiondeficit/hyperactivity disorder

Interventions

None listed

Sponsors

Universitair Medisch Centrum Sint Radboud
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: For all groups inclusion criteria will be: (1) Age between 20 and 40 years old. (2) Estimated IQ above 80. In the ADHD group subjects should be diagnosed with ADHD, combined type, based on psychiatric consultation and meet DSM criteria for ADHD as specified in DSM-IV and have a clinical score on the Conners* Rating Scale Revised (CRS-R). In the ASD group subjects should be diagnosed with autism based on psychiatric consultation and meet DSM criteria for autistic disorder or Aspergers Syndrome as specified in DSM-IV and have a clinical score on the autism diagnostic interview revised (ADI-R).

Exclusion criteria

Exclusion criteria: For all groups exclusion criteria will be: (1) (Co-morbid) psychiatric or neurological disorders. (2) The use of psychotropic medication except for psychostimulants (methylphenidate). Symptomatology should tolerate temporal seizure of psychostimulant-use (see *ethical considerations* in researchprotocol).

Design outcomes

Primary

MeasureTime frame
Alpha-lateralization index

Secondary

MeasureTime frame
Not applicable.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)